4//SEC Filing
Fairmount Healthcare Fund II L.P. 4
Accession 0001104659-25-102606
CIK 0001590750other
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 4:30 PM ET
Size
9.7 KB
Accession
0001104659-25-102606
Insider Transaction Report
Form 4
Fairmount Funds Management LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2025-10-23$22.00/sh+454,545$9,999,990→ 3,914,458 total(indirect: Fairmount Healthcare Fund II LP)
Fairmount Healthcare Fund II L.P.
Director10% Owner
Transactions
- Purchase
Common Stock
2025-10-23$22.00/sh+454,545$9,999,990→ 3,914,458 total(indirect: Fairmount Healthcare Fund II LP)
Fairmount Healthcare Fund II GP LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2025-10-23$22.00/sh+454,545$9,999,990→ 3,914,458 total(indirect: Fairmount Healthcare Fund II LP)
Footnotes (1)
- [F1]Fairmount Funds Management LLC ("Fairmount") and Fairmount Healthcare Fund II GP LLC ("Fairmount GP II") have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.
Documents
Issuer
Viridian Therapeutics, Inc.\DE
CIK 0001590750
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001769651
Filing Metadata
- Form type
- 4
- Filed
- Oct 26, 8:00 PM ET
- Accepted
- Oct 27, 4:30 PM ET
- Size
- 9.7 KB